CRUISE Study Results May Provide Rationale For IVUS Reimbursement
This article was originally published in The Gray Sheet
Executive Summary
Recent study findings that stent placement via intravascular ultrasound guidance is associated with less under-expansion and lower restenosis rates provide a rationale for broader insurance reimbursement of IVUS-guided stenting.
You may also be interested in...
Intravascular Ultrasound Device Expert Added To FDA Commissioner Pool
Among alternative FDA commissioner candidates being considered by the Bush administration is intravascular ultrasound (IVUS) device authority Paul Yock, MD, who brings considerable expertise in product development.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.